311 related articles for article (PubMed ID: 18434153)
21. 2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.
Motiur Rahman AF; Liang JL; Lee SH; Son JK; Jung MJ; Kwon Y; Jahng Y
Arch Pharm Res; 2008 Sep; 31(9):1087-93. PubMed ID: 18806949
[TBL] [Abstract][Full Text] [Related]
22. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
Garcia-Carbonero R; Supko JG
Clin Cancer Res; 2002 Mar; 8(3):641-61. PubMed ID: 11895891
[TBL] [Abstract][Full Text] [Related]
23. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan.
Danks MK; Garrett KE; Marion RC; Whipple DO
Cancer Res; 1996 Apr; 56(7):1664-73. PubMed ID: 8603418
[TBL] [Abstract][Full Text] [Related]
24. Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin.
Dallavalle S; Ferrari A; Merlini L; Penco S; Carenini N; De Cesare M; Perego P; Pratesi G; Zunino F
Bioorg Med Chem Lett; 2001 Feb; 11(3):291-4. PubMed ID: 11212094
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, topoisomerase I inhibitory activity and in vitro cytotoxicity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents.
Zhao R; Guan LL; Oreski B; Lown JW
Anticancer Drug Des; 1998 Mar; 13(2):145-57. PubMed ID: 9524556
[TBL] [Abstract][Full Text] [Related]
26. Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity.
Beretta GL; Zunino F
Biochem Pharmacol; 2007 Nov; 74(10):1437-44. PubMed ID: 17540344
[TBL] [Abstract][Full Text] [Related]
27. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
Jung LL; Zamboni WC
Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of new camptothecin analogs with improved antitumor activities.
Niizuma S; Tsukazaki M; Suda H; Murata T; Ohwada J; Ozawa S; Fukuda H; Murasaki C; Kohchi M; Morikami K; Yoshinari K; Endo M; Ura M; Tanimura H; Miyazaki Y; Takasuka T; Kawashima A; Nanba E; Nakano K; Ogawa K; Kobayashi K; Okabe H; Umeda I; Shimma N
Bioorg Med Chem Lett; 2009 Apr; 19(7):2018-21. PubMed ID: 19254843
[TBL] [Abstract][Full Text] [Related]
29. [Current status of camptothecin derivatives as natural antitumor agents].
Pan XD; Wang CY
Yao Xue Xue Bao; 2003 Sep; 38(9):715-20. PubMed ID: 14730926
[No Abstract] [Full Text] [Related]
30. Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin.
Zu YG; Li QY; Fu YJ; Wang W
Bioorg Med Chem Lett; 2004 Aug; 14(15):4023-6. PubMed ID: 15225719
[TBL] [Abstract][Full Text] [Related]
31. Camptothecin-7-yl-methanthiole: semisynthesis and biological evaluation.
Christodoulou MS; Zunino F; Zuco V; Borrelli S; Comi D; Fontana G; Martinelli M; Lorens JB; Evensen L; Sironi M; Pieraccini S; Dalla Via L; Gia OM; Passarella D
ChemMedChem; 2012 Dec; 7(12):2134-43. PubMed ID: 23086693
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity of aromatic camptothecin esters.
Cao Z; Mendoza J; Dejesus A; Vardeman D; Giovanella B
Int J Mol Med; 2008 Apr; 21(4):477-87. PubMed ID: 18360694
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor activity of novel 20s-camptothecin analogues.
Li Q; Lv H; Zu Y; Qu Z; Yao L; Su L; Liu C; Wang L
Bioorg Med Chem Lett; 2009 Jan; 19(2):513-5. PubMed ID: 19056266
[TBL] [Abstract][Full Text] [Related]
34. Novel 7-substituted camptothecins with potent antitumor activity.
Dallavalle S; Delsoldato T; Ferrari A; Merlini L; Penco S; Carenini N; Perego P; De Cesare M; Pratesi G; Zunino F
J Med Chem; 2000 Oct; 43(21):3963-9. PubMed ID: 11052801
[TBL] [Abstract][Full Text] [Related]
35. The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cells.
Bence AK; Mattingly CA; Burke TG; Adams VR
Cancer Chemother Pharmacol; 2004 Oct; 54(4):354-60. PubMed ID: 15197485
[TBL] [Abstract][Full Text] [Related]
36. Novel camptothecin derivatives.
Legarza K; Yang LX
In Vivo; 2005; 19(1):283-92. PubMed ID: 15796188
[TBL] [Abstract][Full Text] [Related]
37. A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage.
Liu Y; Zhang J; Feng S; Zhao T; Li Z; Wang L; Wang P; Du H; Yuan S; Sun L
Anticancer Agents Med Chem; 2019; 19(3):365-374. PubMed ID: 30523769
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor activity of novel substituted uracil-1'(N)-acetic acid ester derivatives of 20(S)-camptothecins.
Li DZ; Zhang QZ; Wang CY; Zhang YL; Li XY; Huang JT; Liu HY; Fu ZD; Song HX; Lin JP; Ji TF; Pan XD
Eur J Med Chem; 2017 Jan; 125():1235-1246. PubMed ID: 27871039
[TBL] [Abstract][Full Text] [Related]
39. Camptothecins: a SAR/QSAR study.
Verma RP; Hansch C
Chem Rev; 2009 Jan; 109(1):213-35. PubMed ID: 19099450
[No Abstract] [Full Text] [Related]
40. Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.
Nagarajan M; Morrell A; Fort BC; Meckley MR; Antony S; Kohlhagen G; Pommier Y; Cushman M
J Med Chem; 2004 Nov; 47(23):5651-61. PubMed ID: 15509164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
